DCPH 25.59 (+0%)
US24344T1016BiotechnologyBiotechnology

Deciphera Pharmaceuticals (DCPH) Stock Highlights

25.59 | +0%
2024-12-21 03:27:59
Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition, it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations function through the region of the United States.

Statistics

Range Today
25.59 25.59
Volume Today 0
Range 1 Year
9.9 25.61
Volume 1 Year 222.7M
Range 3 Year
6.51 38.91
Volume 3 Year 725.68M
Range 10 Year
6.51 71.11
Volume 10 Year 1.08B

Highlights

Market Capitalization 2.21B (mid)
Floating Shares 46.43M
Current Price 25.59
Price To Earnings -11.57
Price To Revenue 11.24
Price To Book 6.65
Earnings Per Share -2.21
Payout Ratio 0%

Performance

Latest 0%
1 Month +0.75%
3 Months +49.91%
6 Months +72.79%
1 Year +82.14%
3 Years -24.93%
5 Years +16.74%
10 Years +27.57%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.